Kyoto, Japan

Shinichi Mae

This inventor holds 4 USPTO granted patents. Top assignees: Kyoto University, Hokkaido University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shinichi Mae. Retrieved from https://idiyas.com/inventor/shinichi-mae-b46k4yk8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 75.0

Average Co-Inventor Count = 3.3

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Shinichi Mae

Introduction

Shinichi Mae is a notable inventor based in Kyoto-shi, Kyoto, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment and prevention of renal cystic ciliopathy. His innovative work has led to the development of a unique pharmaceutical composition that addresses this medical condition.

Latest Patents

Shinichi Mae holds 1 patent for his invention titled "Pharmaceutical Composition for Treating and/or Preventing Renal Cystic Ciliopathy." This patent showcases his dedication to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Shinichi Mae has been associated with prestigious institutions such as Kyoto University and Hokkaido University. His work at these universities has allowed him to collaborate with leading researchers and contribute to groundbreaking studies in his field.

Collaborations

Shinichi Mae has worked alongside esteemed colleagues, including Kenji Osafune and Saori Nishio. Their collaborative efforts have further enhanced the impact of his research and innovations.

Conclusion

Shinichi Mae's contributions to the field of pharmaceuticals exemplify the importance of innovation in addressing complex medical challenges. His work continues to inspire future advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…